On August 31, 2022 Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, AUG 31, 2022, View Source [SID1234618834]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

– Pareto Securities, 13th Annual Healthcare Conference – Stockholm, Sweden
September 8, 2022

– Transgene’s R&D Day – Paris, France
September 27, 2022

– Investor Access Forum – Paris, France
October 6 & 7, 2022

– HealthTech Innovation Days 2022 – Paris, France
October 13 & 14, 2022

– EigenKapitalForum – Frankfurt (Main), Germany
November 28, 2022

On August 31, 2022 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported that the company will participate in a fireside chat at the Wells Fargo Healthcare Conference on Friday, September 9, 2022 at 11:00 a.m. ET (Press release, Vertex Pharmaceuticals, AUG 31, 2022, View Source [SID1234618833]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of management’s remarks will be available through Vertex’s website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcasts will be archived on the company’s website.

On August 31, 2022 argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, reported that members of management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 8:00 a.m. E.T. in Boston, MA (Press release, argenx, AUG 31, 2022, View Source [SID1234618831]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the presentation.

On August 31, 2022 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, reported that it will present a company update at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022 (Hybrid Conference) (Press release, Anixa Biosciences, AUG 31, 2022, https://ir.anixa.com/news/detail/1000/anixa-biosciences-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference [SID1234618830]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will provide an overview of Anixa’s business and highlight recent corporate achievements, including the treatment of the first patient in Anixa’s CAR-T based ovarian cancer clinical trial.

A replay of the presentation will be available for 90 days at the link above or by visiting the Investors section of Anixa’s website at View Source

Anixa management will also be available for one-on-one meetings throughout the conference. Please contact your representative at H.C. Wainwright to request a meeting.

On August 31, 2022 AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reported that members of its senior management team are scheduled to participate in three investor conferences in September, including (Press release, AVEO, AUG 31, 2022, View Source [SID1234618829]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 Wells Fargo Healthcare Conference
Date: Wednesday – Friday, September 7th – 9th
Format: 1×1 Investor Meetings

H.C. Wainwright 24th Annual Global Investment Conference
Date: Monday, September 12th at 5:00 p.m. Eastern Time
Format: Fireside Chat and 1×1 Investor Meetings
Details: A live webcast of the H.C. Wainwright fireside chat can be accessed by visiting the investors section of the Company’s website at www.aveooncology.com. A replay of the webcast will be archived for 90 days following the presentation date.

Baird 2022 Global Healthcare Conference
Date: Tuesday, September 13th at 11:25 a.m. Eastern Time
Format: Presentation and 1×1 Investor Meetings